Adenoviral Delivery of CRISPR/Cas9 Aims to Expand Genome Editing to Primary Cells
Type
Blog Post
Description
The development of adenoviral vectors for the delivery of CRISPR/Cas9 expands genome engineering to primary cells.
Published
Dec. 10, 2020, 1 p.m.